More about

Cholestasis

News
January 06, 2020
1 min read
Save

Maralixibat on path to new drug application for Alagille syndrome-pruritus

Mirum Pharmaceuticals completed a clinical pre-new drug application meeting with the FDA for maralixibat, the company’s therapeutic candidate for the treatment of Alagille syndrome-associated pruritus, according to a press release.

View more